Luxembourg-based space biotechnology company and pre-clinical CRO developing the Orbital High-Throughput Screening (OHTS) platform, an automated miniaturized lab for large-scale drug discovery and disease modeling in microgravity.
Luxembourg-based space biotechnology company and pre-clinical CRO developing the Orbital High-Throughput Screening (OHTS) platform, an automated miniaturized lab for large-scale drug discovery and disease modeling in microgravity.
Suppliers, customers & partners
Suppliers & service providers to Exobiosphere
Voyager Technologies— customer · mission management and integration partner · 1 more roles5 connectionsTell me more
Voyager (Voyager Technologies Europe) was contracted to provide mission management services and serve as mission integrator on the ISS for Exobiosphere's Orbital High-Throughput Screener (OHTS) biology platform, enabling Exobiosphere's automated biological research in microgravity.
Relationship research record
Voyager Technologies supplies full mission management services on the ISS for Exobiosphere (contract announced May 2026).
Relationship research record
Voyager Technologies provides mission integrator services, project management, safety and verification to NASA standards, ISS integration, and on-orbit operations coordination for Exobiosphere’s Orbital High-Throughput Screener (OHTS) payload under a 2026 contract.
Relationship research record
Voyager Technologies provides mission management services to Exobiosphere for missions to operate Exobiosphere payloads (e.g., enabling access to the ISS and other platforms through Voyager's mission management capabilities).
Relationship research record
Voyager is the mission management partner that will facilitate Exobiosphere's first automated drug‑screening mission on the International Space Station (Voyager supplies mission operations and integration services to enable Exobiosphere experiments on the ISS).
Relationship research record
Vast— customer · supplier2 connectionsTell me more
Exobiosphere flies a biotechnology payload for pharmaceutical and healthcare experiments on Haven-1 (announced April 2025).
Relationship research record
Vast provides the Haven-1 commercial space station platform that will host Exobiosphere's Orbital High-Throughput Screener (OHTS); Vast's station infrastructure enables Exobiosphere to operate automated biology experiments in low Earth orbit.
Exobiosphere will deliver a complete end‑to‑end automated biology research service in low Earth orbit (hardware, operations, open-science selection and data return) under an ESA-awarded contract for microgravity science and research utilisation.
Exobiosphere will provide its automated Orbital High‑Throughput Screener (OHTS) payload and drug‑screening services for a Voyager‑managed mission on the International Space Station (Exobiosphere supplies payload capability and research services; Voyager acts as the mission host/manager for that mission).
Relationship research record
Exobiosphere program partners
Vast— payload partner and platform supplier · platform customer / mission user2 connectionsTell me more
Exobiosphere supplies and installs its Orbital High-Throughput Screening (OHTS) platform/payload on Vast’s Haven-1 commercial space station Lab for microgravity pharmaceutical and healthcare experiments (announced 2025, mission targeted for 2026).
Relationship research record
Exobiosphere will install its Orbital High‑Throughput Screening device (OHTS) aboard Vast's Haven‑1 commercial space station to run thousands of automated biological experiments in microgravity — Exobiosphere supplies OHTS hardware and in‑orbit research services to Vast's Haven‑1 platform.
ESA awarded Exobiosphere a contract under the End-to-End Utilisation Service Procurement for Science and Research in Microgravity to design, qualify, and operate a full-service automated biology platform in LEO — an enabling procurement and program partnership that funds and scopes Exobiosphere's orbital hardware and operations development.
Relationship research record
Cedars-Sinai— mission user and research partnerTell me more
Exobiosphere supplies its automated biomedical research hardware/platform to Cedars-Sinai investigators for organoid and disease modeling experiments aboard Vast’s Haven-1 space station (partnership announced December 2025, leveraging Cedars-Sinai’s investment and accelerator participation).
Relationship research record
Explore Exobiosphere in context
← Suppliers to Exobiosphere0 companies · Browse profilesCompanies supplied by Exobiosphere →1 companies · Browse profiles
Highlighted companies match the selected filters. Smaller translucent companies are their direct connections across every scale and segment. Circle size reflects connection prominence, not a ranking or valuation.
Peer companies
Other spacecraft & satellite platforms companies in space hardware.